Nesiritide
CLevel 1 evidenceNesiritide
Basic Information
Recombinant human Natriuretic Peptide
The FDA approved (2001) recombinant human B-type natriuretic peptide for short-term symptom relief in acute decompensated heart failure via IV bolus and infusion, but it is now rarely used.
Efficacy Rating
Class C
No data available
No data available
China Regulatory Status
No data available
No data available
No data available
Similar Peptide Recommendations
ANP
ANP
Endocardial, cardiac, natriuretic peptide
BNP
BNP
endogenous, cardiac, biomarker
C-Type Natriuretic Peptide
C-Type Natriuretic Peptide
endogenous, natriuretic peptide, endothelium
Vosoritide
Vosoritide
FDA-approved, rare disease, pediatric
Disclaimer
The content on this platform is for educational and informational purposes only and does not constitute medical advice, formulation guidance, or a guarantee of regulatory compliance. All efficacy claims are labeled with their evidence level; please consult a professional before making any decisions.